New DNA reader may crack the code of mysterious childhood epilepsy

NCT ID NCT07396883

First seen Feb 10, 2026 · Last updated Apr 24, 2026 · Updated 4 times

Summary

This study tests a new DNA-reading technology called long-read genome sequencing in 20 children with severe epilepsy whose standard genetic tests came back normal. The goal is to find hidden genetic errors that current methods miss. If successful, this could lead to better treatments and genetic counseling for families.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Memorial Hospital

    Reims, 51092, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Jean Minjoz

    Besançon, 25000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Nancy - hôpital d'enfant

    Vandœuvre-lès-Nancy, 54511, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpitaux Universitaires de Strasbourg

    Strasbourg, 67098, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.